ClinicalTrials.Veeva

Menu

Velacur by Sonic Incytes for Portal Hypertension

Indiana University logo

Indiana University

Status

Completed

Conditions

Portal Hypertension
Chronic Advanced Liver Disease

Treatments

Diagnostic Test: Velacur

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04576897
LI for Portal Hypertenstion
2009698702 (Other Identifier)

Details and patient eligibility

About

This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.

Full description

The purpose of this study is to assess the severity of portal hypertension in people with compensated advanced chronic liver disease (cACLD) who have not undergone liver transplant by measuring liver stiffness with the Liver Incytes device (Velacur) and comparing the performance of LSM (liver stiffness measurement) via Velcaur and transient elastography via FibroScan to esophageal varices.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults aged 18 years or older
  2. Ability to provide informed consent
  3. Planned standard of care upper endoscopy to screen for varices
  4. Planned standard of care transjugular liver biopsy with portal pressure measurement

Exclusion criteria

  1. Inability or refusal to provide informed consent
  2. Fasting for less than three hours prior to the scan
  3. Subject is a pregnant or lactating female
  4. Subject with current, significant alcohol consumption
  5. Patients with a pacemaker or defibrillator
  6. Acute hepatitis defined as AST/ALT > 500 U/L
  7. Ascites
  8. post liver transplantation

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

Velacur by Sonic Incytes
Experimental group
Description:
Patients with compensated advanced chronic liver disease (cACLD) who have not undergone liver transplantation will be scanned with Velacur.
Treatment:
Diagnostic Test: Velacur

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Samer Gawrieh, MD; Regina Weber, BS, RRT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems